最近,许多研究报道了阿司匹林作为结直肠癌辅助化疗药物可能具有的效果,提示其可能对确诊患者的预后有积极作用。本研究旨在研究对于直肠癌患者术前放化疗中应用阿司匹林的抗肿瘤效果。Restivo A等人选取241例确诊为Ⅱ~Ⅲ期直肠癌且接受放化疗的患者进入本研究,一组患者为确诊为直肠癌时即开始服用阿司匹林组,另外一组患者确诊为直肠癌后未服用阿司匹林组。比较2组患者的治疗结果及肿瘤结果。结果发现,服用阿司匹林的患者有更高的肿瘤降期率(67.6%比 Recently, many studies reported the possible effect of aspirin as adjuvant chemotherapy for colorectal cancer, suggesting that it may have a positive effect on the prognosis of patients diagnosed. The aim of this study was to investigate the antitumor effect of aspirin in preoperative chemoradiation in patients with rectal cancer. Restivo A and others selected 241 patients diagnosed with stage Ⅱ ~ Ⅲ rectal cancer and received radiotherapy and chemotherapy patients into the study, a group of patients diagnosed with rectal cancer began to take aspirin group, another group of patients diagnosed with rectal cancer after Taking aspirin group. The treatment outcome and tumor outcome in two groups were compared. The results showed that patients taking aspirin had a higher rate of tumor down (67.6% than